BridgeMD
Prevention study for Alopecia
Official title Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
ClinicalTrials.gov ID: NCT04764357
What this study is testing
- What it's testing
- This study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditions or solid tumors. Primary Objective To assess the safety and feasibility of the use of a scalp cooling device in pediatric and young adult patients receiving chemotherapy for non-malignant conditions and solid tumors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 and older
You may be able to join if
- Patients receiving a chemotherapeutic agent likely to cause alopecia. Any patient receiving the following drugs may experience complete alopecia...
- Diagnosed with a non-malignant condition (such as Sickle Cell Disease or Aplastic Anemia) OR Diagnosed with a solid tumor (non-brain tumor)
- Patients must be at least 7 years old
- Patients should have a head circumference of 50 cm or greater
You likely can't join if
- Patients receiving a chemotherapeutic agent for a hematologic malignant/neoplastic condition.
- Patients with neoplasm of the brain or scalp, or present scalp metastasis, or high risk of metastatic disease to the brain or scalp (for example...
- Patients who are unfit for the study based on the opinion of the primary investigator and/or the patient's primary team.
- Patients with a previous history of adverse event associated with the Paxman scalp kit or scalp cooling device
- Patients with cold agglutinin disease or cold urticaria
- Inability or unwillingness of research participant or legal guardian/representative to give written informed consent
See the full eligibility criteria
- Patients receiving a chemotherapeutic agent likely to cause alopecia. Any patient receiving the following drugs may experience complete alopecia (dose and schedule dependent). If they are receiving such a drug for a...
- Diagnosed with a non-malignant condition (such as Sickle Cell Disease or Aplastic Anemia) OR Diagnosed with a solid tumor (non-brain tumor)
- Patients must be at least 7 years old
- Patients should have a head circumference of 50 cm or greater
- Patients receiving a chemotherapeutic agent for a hematologic malignant/neoplastic condition.
- Patients with neoplasm of the brain or scalp, or present scalp metastasis, or high risk of metastatic disease to the brain or scalp (for example, neuroblastoma, melanoma or other skin malignancies, or patients who have...
- Patients who are unfit for the study based on the opinion of the primary investigator and/or the patient's primary team.
- Patients with a previous history of adverse event associated with the Paxman scalp kit or scalp cooling device
- Patients with cold agglutinin disease or cold urticaria
- Inability or unwillingness of research participant or legal guardian/representative to give written informed consent
- Patients with an active infection/infestation of scalp at the time of study enrollment
The study team makes the final eligibility decision.
Where it's taking place
- Memphis, Tennessee, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.